mRNA疫苗研发的市场风险应对策略分析  

Analysis of Market Risk Coping Strategies in mRNA Vaccine R&D

作　　者：张杏[1] 刘丹丹[1] ZHANG Xing;LIU Dan-dan(School of Pharmacy,Fujian Health College,Fuzhou 350101,China)

机构地区：[1]福建卫生职业技术学院药学院,福建福州350101

出　　处：《海峡药学》2025年第2期101-104,共4页Strait Pharmaceutical Journal

基　　金：福建省中青年教师教育科研项目(JAT201219);福建卫生职业技术学院专业建设与教学改革项目药品经营与管理专业教学创新团队(JG2022102)。

摘　　要：本文通过文献研究法,识别出我国mRNA疫苗研发的市场风险主要来源于产品自身、需求、供应链、竞争、定价、知识产权和政策方面,在此基础上详细分析了各个具体的市场风险因素。通过现状分析及资料整理,有针对性地提出对策,并为下一步建立mRNA疫苗研发的市场风险评估体系奠定基础。Through the literature research method,this paper identifies the market risks of mRNA vaccine research and development in China,which mainly stem from the aspects of product itself,demand,supply chain,competition,pricing,intellectual property rights,and policies.On this basis,each specific market risk factor was analyzed in detail.Through current situation analysis and data sorting,the countermeasures were put forward,and the foundation was laid for the next step to establish the market risk assessment system of mRNA vaccine research and development.

关 键 词：mRNA疫苗研发 市场风险 应对策略 

分 类 号：R969.4[医药卫生—药理学]